News
Successful isolation of a antibody against Ebola
healthcare-in-europe.com
“Once again we have proven that Humabs is able to discover and develop anti-infective antibodies with high speed and remarkable results,” said Filippo Riva, CEO of Humabs. “This includes antibodies directed against emerging novel pathogens, such as MERS coronavirus and Zika virus.
Futuro assicurato per Humabs - RSI Radiotelevisione svizzera
www.rsi.ch
Futuro assicurato per Humabs - La ditta bellinzonese acquisita da un colosso americano della ricerca biomedica che ne garantirà lo sviluppo
Swiss Biotech Association Strengthens Its Board of Directors and...
www.b3cnewswire.com
The Swiss Biotech Association appointed Dr. Patrick Amstutz (CEO of Molecular Partners) and Filippo Riva (CEO of Humabs Biomed) at its ...
Humabs BioMed eröffnet neues Forschungslabor | S-GE
www.s-ge.com
Humabs BioMed hat ein neues Forschungslabor in Bellinzona eingeweiht. Das Tessiner Biotech-Unternehmen gehört seit zwei Jahren zum amerikanischen Konzern Vir...
sortiert nach Relevanz / Datum